228 related articles for article (PubMed ID: 31347325)
1. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
2. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker.
Lim JB; Kim DK; Chung HW
Cancer Sci; 2014 Oct; 105(10):1327-33. PubMed ID: 25154912
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.
Chung HW; Kong HY; Lim JB
World J Gastroenterol; 2015 Feb; 21(7):2080-8. PubMed ID: 25717241
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.
Chung HW; Lim JB
J Transl Med; 2014 Apr; 12():102. PubMed ID: 24745825
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
Li Y; Sun H; Guan J; Ji T; Wang X
Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
[TBL] [Abstract][Full Text] [Related]
7. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytokine profiling in serum for early detection of gastric cancer.
Li J; Xu L; Run ZC; Feng W; Liu W; Zhang PJ; Li Z
World J Gastroenterol; 2018 Jun; 24(21):2269-2278. PubMed ID: 29881236
[TBL] [Abstract][Full Text] [Related]
9. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X
Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616
[TBL] [Abstract][Full Text] [Related]
10. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
11. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
12. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
13. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
Huang M; He YR; Liang LC; Huang Q; Zhu ZQ
World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900
[TBL] [Abstract][Full Text] [Related]
15. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.
Wu Y; Jiang M; Qin Y; Lin F; Lai M
Clin Chim Acta; 2018 Jun; 481():20-24. PubMed ID: 29476736
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
[TBL] [Abstract][Full Text] [Related]
17. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
18. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients.
Li L; Yin X; Meng H; Hu J; Yu Z; Xu J
Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795
[TBL] [Abstract][Full Text] [Related]
19. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
20. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
